BiohacksAI/Targets/SRMS/Compounds

Compounds That Target SRMS

src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites · 18 compounds in BiohacksAI corpus

SRMS (src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites) is a biological target with 18 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into SRMS modulation for therapeutic and biohacking applications.

View SRMS target page →UniProt: Q9H3Y6 ↗

Most Studied Compounds for SRMS

Sorafenib

300+

studies

Dasatinib

299+

studies

All 18 Compounds — Ranked by Evidence

Alvocidib

4.52

confidence

Foretinib

4.34

confidence

Vandetanib

4.30

confidence

Bosutinib

4.08

confidence

Pazopanib

3.69

confidence

Canertinib

3.53

confidence

Tae 684

3.43

confidence

Fedratinib

3.40

confidence

Lestaurtinib

3.04

confidence

Defosbarasertib

2.89

confidence

R 406

2.83

confidence

Plx 4720

2.71

confidence

Kw 2449

2.64

confidence

Ast 487

2.56

confidence

Su 014813

2.20

confidence

Rebastinib

2.20

confidence

Sorafenib

300+

studies

1.39

confidence

Dasatinib

299+

studies

1.10

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for SRMS (src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: SRMS target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.